Gene silencing versus protein stabilization in transthyretin amyloid cardiomyopathy: contextualizing the HELIOS-B results and the road to precision agent selection.

Attruby (acoramidis) - BridgeBio

Wainua (eplontersen) - Ionis, AstraZeneca

Vyndaqel (tafamidis meglumine) - Pfizer

Amvuttra (vutrisiran) - Alnylam

http://www.ncbi.nlm.nih.gov/pubmed/42433826

Muhammad Adnan Qamar; Muhammad Sajjad Ul Haque; Sarum Ali Khan; Taimoor Ali

Jul 12, 2026